RAS Status May Guide Cetuximab Or Bevacizumab Choice For Metastatic Colorectal Cancer

Head-to-head trial of cetuximab and bevacizumab with chemotherapy for the first-line treatment of metastatic colorectal cancer brings mixed results...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.